1. Home
  2. SPCB vs MDXH Comparison

SPCB vs MDXH Comparison

Compare SPCB & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SuperCom Ltd. (Israel)

SPCB

SuperCom Ltd. (Israel)

HOLD

Current Price

$9.90

Market Cap

63.2M

Sector

Technology

ML Signal

HOLD

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$0.72

Market Cap

68.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPCB
MDXH
Founded
1988
2003
Country
Israel
Belgium
Employees
N/A
N/A
Industry
Semiconductors
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
63.2M
68.7M
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
SPCB
MDXH
Price
$9.90
$0.72
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
92.5K
845.5K
Earning Date
04-28-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$30.78
Revenue Next Year
$27.13
$18.31
P/E Ratio
$10.36
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.07
$0.40
52 Week High
$13.57
$5.33

Technical Indicators

Market Signals
Indicator
SPCB
MDXH
Relative Strength Index (RSI) 40.11 54.38
Support Level $9.49 $0.68
Resistance Level $10.78 $1.13
Average True Range (ATR) 0.36 0.05
MACD -0.05 -0.01
Stochastic Oscillator 16.79 28.64

Price Performance

Historical Comparison
SPCB
MDXH

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: